Dry mouth (also known as xerostomia), is a significant problem faced by adults and unless due to a side effect from medication, there is no real cure. Often the reason for a case of dry mouth isn’t known, but some common causes include medications, head and neck radiation therapy for cancer, Sjogren’s syndrome, and type…
FDA Approves First Treatment for Tardive Dyskinesia
Repetitive involuntary movements typically affecting the jaw, lips, tongue, arms or legs can be caused by tardive dyskinesia, a neurological disorder. Tardive dyskinesia is often seen as a side effect in patients taking antipsychotic medications used to treat certain mental illnesses. Previously, no medications were FDA approved to specifically treat tardive dyskinesia, making prevention key. This…
FDA Approves Renflexis, Second Biosimilar for Remicade
On April 21st, the FDA approved Renflexis (infliximab-abda), the second biosimilar to the popular medication Remicade, (infliximab) indicated for immune disorders. A biosimilar is like a generic medication in that it is less expensive than the brand name medication. However, the difference is that biosimilars are made out living cells, so they may be slightly different from their…
New Lower Prices for More Brand-Name Drugs!
Last week, GoodRx rolled out exclusive new savings on more than 40 brand-name prescriptions, and we also promised to pursue discounts for more drugs. Today, we’re happy to announce new Inside Rx discounts for 6 more brands: Colcrys (treats gout): 45% off retail price Uloric (treats gout): 16% off retail price Amitiza (treats constipation): 40% off retail…
Can Nasal Bactroban Before Surgery Prevent MRSA?
Methicillin-resistant Staphylococcus aureus (MRSA) surgical site infections have been catastrophic for patients—they result in longer hospital stays and poorer outcomes. More than 80% of the time, infections result because of Staph aureus that we are carrying, in our nose or on our skin. For those of us who may be carriers of Staph aureus (it…
FDA Updates Safety Warnings for Fluoroquinolone Antibiotics
On May 10th, 2017, the FDA issued a safety update on fluoroquinolone antibiotics, like Cipro and Levaquin, as part of an ongoing review. About a year ago, the FDA released findings that fluoroquinolone antibiotics can cause dangerous side effects involving the tendons, muscles, joints, nerves and central nervous system, and advised that use should be restricted in uncomplicated…
New FDA Approval: Tymlos for Osteoporosis
Osteoporosis affects one in four women ages 65 and older, making it more likely that you will break a bone in the hip, forearm, wrist, or spine. Osteoporosis occurs when you lose bone, don’t make enough bone, or a combination—and it can be caused by many things, including genetic makeup, diet, diseases and even some…
Public Notification: Black 3K Plus Male Sexual Enhancement Capsules Contain Hidden Drug Ingredient
[12-22-2016] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Black 3K Plus Male Sexual Enhancement Capsules, a product promoted for sexual enhancement. This product was identified by FDA during an examination of international mail shipments. FDA laboratory analysis confirmed that Black 3K Plus Male…
Public Notification: Rhino 7K 9000 Male Performance Booster Contains Hidden Drug Ingredient
[12-22-2016] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Rhino 7K 9000 Male Performance Booster, a product promoted for sexual enhancement. This product was identified by FDA during an examination of international mail shipments. FDA laboratory analysis confirmed that Rhino 7K 9000 Male Performance…
Public Notification: Rhino 8 Platinum 8000 Contains Hidden Drug Ingredient
[12-22-2016] The Food and Drug Administration (FDA) is advising consumers not to purchase or use Rhino 8 Platinum 8000, a product promoted for sexual enhancement. This product was identified by FDA during an examination of international mail shipments. FDA laboratory analysis confirmed that Rhino 8 Platinum 8000 contains sildenafil, the…